ELDN
Eledon Pharmaceuticals Inc
2.70$
-1.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 152.5% | 162.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -152.5% | 100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 5,109.2% | 19,779.2% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 8,376.7% | 10,943.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 15,387.5% | 30,722.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -15,387.5% | -30,722.5% | – | – | – | – | |
| – | – | – | – | – | – | – | – | 8,048.3% | 168.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -19,345.8% | -30,716.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -336.7% | -1,961.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -19,009.2% | -28,755.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -13,333.3% | -30,560.0% | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.